<p>The increasing resistance of <i>Pseudomonas aeruginosa</i> to carbapenem antibiotics is shifting the landscape of high-risk clones from a strictly hospital-acquired threat to a global pathogen with One Health relevance. Given the limited therapeutic options available, developing new treatments is essential. We previously reported the complete genome sequence of φSPM-1 phage from the family <i>Myoviridae</i>. In this study, we show that φSPM-1 displays lytic activity against hospital and environmental metallo-β-lactamase (MβL)-producing <i>P. aeruginosa</i> and confers a protective effect against lethal infection caused by the high-risk clone ST277 in a <i>Galleria mellonella</i> prophylactic model.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Lytic activity of F8-like phage φSPM-1 against One Health lineages of carbapenem-resistant Pseudomonas aeruginosa

  • Patrícia R. Neves,
  • Karine Dantas,
  • Gregory Melocco,
  • Helena Turano,
  • Fernanda Esposito,
  • Ana C. Gales,
  • Carlo E. Levy,
  • Elsa M. Mamizuka,
  • Nilton Lincopan

摘要

The increasing resistance of Pseudomonas aeruginosa to carbapenem antibiotics is shifting the landscape of high-risk clones from a strictly hospital-acquired threat to a global pathogen with One Health relevance. Given the limited therapeutic options available, developing new treatments is essential. We previously reported the complete genome sequence of φSPM-1 phage from the family Myoviridae. In this study, we show that φSPM-1 displays lytic activity against hospital and environmental metallo-β-lactamase (MβL)-producing P. aeruginosa and confers a protective effect against lethal infection caused by the high-risk clone ST277 in a Galleria mellonella prophylactic model.